Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration

被引：0
|
作者：
Sam Razavi
Laurent Kodjikian
Audrey Giocanti-Aurégan
Ingrid Dufour
Eric Souied
机构：
[1] Centre d’Ophtalmologie,
[2] Centre Hospitalier de la Cr Rousse,undefined
[3] Université de Lyon,undefined
[4] Hôpital Avicenne,undefined
[5] AP-HP,undefined
[6] Université Paris 13,undefined
[7] DHU Vision et Handicaps,undefined
[8] Bayer HealthCare SAS,undefined
[9] Centre Hospitalier Intercommunal de Créteil,undefined
来源：
BMC Ophthalmology | / 21卷
关键词：
Retina; Age-related macular degeneration; Exudative; Switch; Observational;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
    Razavi, Sam
    Kodjikian, Laurent
    Giocanti-Auregan, Audrey
    Dufour, Ingrid
    Souied, Eric
    BMC OPHTHALMOLOGY, 2021, 21 (01)
  • [2] Effect of Aflibercept and Bevacizumab for Ranibizumab-Refractory Exudative Age-Related Macular Degeneration
    Kim, Bo Hee
    Seo, Young Seung
    Chung, Hum
    Heo, Jang Won
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [3] Effects of Intravitreal Aflibercept on Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Ranibizumab
    Suzuki, Katsuya
    Yasukawa, Tsutomu
    Kato, Aki
    Fujino, Shinpei
    Morita, Hiroshi
    Ota, Satoshi
    Hirahara, Shuichiro
    Munenori, Yoshida
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [4] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Rachel Hui Fen Lim
    Bhaskar Gupta
    Peter Simcock
    International Journal of Ophthalmology, 2017, (03) : 423 - 426
  • [5] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Lim, Rachel Hui Fen
    Gupta, Bhaskar
    Simcock, Peter
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (03) : 423 - 426
  • [6] Efficacy of intravitreal aflibercept in exudative age-related macular degeneration (AMD) refractory to intravitreal ranibizumab and bevacizumab
    Lau, Stephen
    Acharya, Nachiketa
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [7] Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab
    Freund, K. Bailey
    Hoang, Quan V.
    Saroj, Namrata
    Thompson, Desmond
    OPHTHALMOLOGY, 2015, 122 (09) : 1802 - 1810
  • [8] Comparison between Aflibercept, Ranibizumab intravitreal injection on Neovascular Age-related macular degeneration patients
    Kwon, Y. H.
    Min, J. S.
    Ahn, H.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [9] Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
    Min, Ji Sang
    Jung, Hyun Chul
    Suh, Ji Young
    Kwon, Yoon Hyung
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (11): : 1738 - 1744
  • [10] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
12345